FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11388811000001108: Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40620701000001111 Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
43201001000001113 Sirdalud MR 12mg modified-release capsules (Imported (Switzerland)) 30 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction imported true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Is a Tizanidine 12mg modified-release capsules 30 capsule true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Is pack of Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) false Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has active ingredient Tizanidine hydrochloride false Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has active ingredient Tizanidine false Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has manufactured dose form Modified-release oral capsule false Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has AMP Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tizanidine true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has specific active ingredient Tizanidine hydrochloride true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has dispensed dose form Modified-release oral capsule true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Sirdalud MR 12mg modified-release capsules (Novartis Pharma Schweiz AG) 30 capsule Has basis of strength substance Tizanidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start